Documents & Downloads

NDC 1308

Anticancer Agent

NDC 1308 is an estradiol analogue that selectively targets estrogen receptor beta. It exhibits significant anticancer activity by inhibiting cancer cell proliferation through the blockade of chromosome replication. This compound is utilized in research focused on cancer biology, particularly in the study of breast cancer.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	1227511-09-2
Applications	Anticancer Agent
Formula	C₂₅H₃₈O₃
Molecular Weight	386.57
SMILES	C[C@@]12[C@](CC[C@@H]2O)([H])[C@@]3([H])[C@](C4=CC=C(O)C=C4[C@H](CCCCCCOC)C3)([H])CC1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.